This groundbreaking nine-year study used advanced mass spectrometry to analyze lipid profiles in human plasma, revealing dynamic changes tied to aging, insulin resistance, and viral infections. The findings suggest that specific lipid subclasses are crucial indicators and potential targets for treatment in human health and various diseases.
CureVac turns up the heat in ongoing patent litigation with Pfizer – Pharmaceutical Technology
In July 2022, CureVac filed a patent infringement lawsuit against BioNTech and two of its subsidiaries regarding Comirnaty, seeking compensation. Image Credit: Freedomz / Shutterstock.